harmaline has been researched along with pargyline in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (84.21) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, K | 1 |
| Agid, Y; Bockaert, J; Enjalbert, A; Euvrard, C; Glowinski, J; Herbet, A; Javoy, F | 1 |
| Glowinski, J; Hamon, M; Herbet, A; Nelson, DL | 1 |
| Bernasconi, S; Manara, L; Mennini, T; Samanin, R; Serra, G | 1 |
| Fuller, RW; Hemrick, SK | 1 |
| Achee, FM; Gabay, S | 1 |
| Gillis, CN; Roth, JA | 1 |
| Fuentes, JA; Neff, NH | 1 |
| Hall, TR; Harvey, S; Lea, RW; Vowles, DM | 1 |
| Fuller, RW; Hemrick-Luecke, SK; Wong, CJ | 1 |
| de Vlaming, VL; Figueroa, HR; Hall, TR; Olcese, JM | 1 |
| Björklund, A; Sjölund, B; Wiklund, L | 1 |
| Carlson, GM; Gianutsos, G; Godfrey, JG | 1 |
| Fuller, RW; Hemrick-Luecke, SK | 2 |
| Fuller, RW; Hemrick-Luecke, SK; Perry, KW | 1 |
| Abdel-Fattah, AF; El-Hady, KA; Matsumoto, K; Mohamed, MF; Murakami, Y; Watanabe, H | 1 |
| Abdel-Fattah, AF; Adel-Khalek Gammaz, H; Matsumoto, K; Mohamed, MF; Murakami, Y; Watanabe, H | 1 |
| Jiang, XL; Shen, HW; Wu, C; Yu, AM | 1 |
19 other study(ies) available for harmaline and pargyline
| Article | Year |
|---|---|
[Studies on monoamine oxidase. (Report 37) Effects of oxygen concentration on rat liver and brain monoamine oxidase (author's transl)].
Topics: Animals; Brain; Female; Harmaline; Hydrazines; Liver; Mitochondria; Mitochondria, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxygen Consumption; Pargyline; Rats; Serotonin; Tyramine | 1977 |
Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
Topics: Acetylcholine; Adenylyl Cyclases; Alkaloids; Aminobutyrates; Animals; Animals, Newborn; Cerebral Cortex; Corpus Striatum; Depression, Chemical; Dopamine; Fenclonine; gamma-Aminobutyric Acid; Harmaline; Hippocampus; Limbic System; Male; Neural Pathways; Neurons; Parasympathetic Nervous System; Pargyline; Rats; Serotonin; Substantia Nigra; Tectum Mesencephali; Tranylcypromine | 1977 |
[3H]Harmaline as a specific ligand of MAO A--II. Measurement of the turnover rates of MAO A during ontogenesis in the rat brain.
Topics: Aging; Alkaloids; Animals; Binding, Competitive; Brain; Female; Harmaline; Kinetics; Ligands; Male; Monoamine Oxidase; Pargyline; Protein Binding; Rats | 1979 |
The effect of intracerebral 6-hydroxy dopamine on 3H-reserpine binding to different brain regions of the rat.
Topics: Animals; Brain; Female; Harmaline; Hydroxydopamines; Injections, Intraventricular; Pargyline; Rats; Reserpine; Time Factors | 1977 |
Enhanced selectivity of pargyline as an inhibitor of type B monoamine oxidase in harmaline-treated rats.
Topics: Alkaloids; Animals; Brain; Harmaline; Liver; Male; Monoamine Oxidase Inhibitors; Myocardium; Pargyline; Phenethylamines; Rats; Serotonin; Substrate Specificity | 1978 |
Studies of monoamine oxidases. Inhibition of bovine brain MAO in intact mitochondria by selective inhibitors.
Topics: Animals; Brain; Cattle; Clorgyline; Dialysis; Drug Interactions; Harmaline; In Vitro Techniques; Mitochondria; Monoamine Oxidase Inhibitors; Pargyline; Time Factors | 1977 |
Multiple forms of amine oxidase in perfused rabbit lung.
Topics: Animals; Deamination; Dextroamphetamine; Harmaline; In Vitro Techniques; Lung; Monoamine Oxidase; Pargyline; Phenethylamines; Phenoxybenzamine; Rabbits; Semicarbazides; Serotonin; Time Factors | 1975 |
Selective monoamine oxidase inhibitor drugs as aids in evaluating the role of type A and B enzymes.
Topics: Animals; Blepharoptosis; Body Temperature; Clorgyline; Cyclopropanes; Harmaline; In Vitro Techniques; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Pargyline; Phenethylamines; Phenyl Ethers; Rats; Reserpine | 1975 |
Biochemistry and physiology of monoamine oxidase (MAO) activity in the ring dove (Streptopelia risoria). I. Characteristics of MAO activity in vitro.
Topics: Animals; Brain; Columbidae; Female; Harmaline; Kidney; Kinetics; Liver; Monoamine Oxidase; Pargyline; Thermodynamics; Tissue Distribution | 1985 |
MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
Topics: Alkaloids; Animals; Brain; Harmaline; Isoenzymes; Liver; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Oxazolidinones; Pargyline; Time Factors | 1986 |
Effects of inhibitors of monoamine oxidase activity in goldfish (Carassius auratus) brain in vitro.
Topics: Animals; Brain; Clorgyline; Cyprinidae; Goldfish; Harmaline; In Vitro Techniques; Kinetics; Monoamine Oxidase Inhibitors; Pargyline; Selegiline; Time Factors | 1981 |
Morphological and functional studies on the serotoninergic innervation of the inferior olive.
Topics: 5,6-Dihydroxytryptamine; 5,7-Dihydroxytryptamine; Action Potentials; Afferent Pathways; Animals; Autoradiography; Axonal Transport; Cats; Harmaline; Methoxydimethyltryptamines; Microscopy, Fluorescence; Olivary Nucleus; Pargyline; Rats; Seizures; Serotonin; Tritium | 1981 |
Drug-induced changes in motor activity after selective MAO inhibition.
Topics: Amphetamine; Animals; Brain; Clorgyline; Harmaline; Isoenzymes; Levodopa; Male; Mice; Monoamine Oxidase; Motor Activity; Pargyline; Phenethylamines; Propylamines | 1983 |
Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline.
Topics: Animals; Biogenic Amines; Brain; Catecholamines; Harmaline; Hypothalamus; Isoquinolines; Monoamine Oxidase Inhibitors; Pargyline; Rats; Tetrahydroisoquinolines | 1983 |
Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
Topics: Animals; Blood Pressure; Brain Chemistry; Cyclopropanes; Dose-Response Relationship, Drug; Epinephrine; Harmaline; Hypothalamus; Male; Monoamine Oxidase Inhibitors; Neurons; Pargyline; Phenyl Ethers; Rats | 1981 |
Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats.
Topics: Alkaloids; Animals; Catecholamines; Dopamine; Epinephrine; Harmaline; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Rats | 1981 |
Facilitatory and inhibitory effects of harmaline on the tryptophan-induced 5-hydroxytryptamine syndrome and body temperature changes in pargyline-pretreated rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Temperature Regulation; Harmaline; Male; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Wistar; Serotonin; Syndrome; Tryptophan | 1996 |
Central serotonin level-dependent changes in body temperature following administration of tryptophan to pargyline- and harmaline-pretreated rats.
Topics: Animals; Body Temperature; Brain; Dopamine; Harmaline; Male; Monoamine Oxidase Inhibitors; Pargyline; Rats; Rats, Wistar; Serotonin; Tryptophan | 1997 |
Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.
Topics: Animals; Area Under Curve; Bufotenin; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genotype; Half-Life; Harmaline; Hepatocytes; Humans; Isoenzymes; Kinetics; Methoxydimethyltryptamines; Methylation; Mice; Mice, Transgenic; Microsomes, Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Phenotype; Polymorphism, Genetic; Psychotropic Drugs | 2010 |